Evidence map›Paper›PMID 38632591›Full record

ArticleJournal of translational medicine2024

IL-33 regulates adipogenesis via Wnt/β-catenin/PPAR-γ signaling pathway in preadipocytes.

Danning Xu, Siqi Zhuang, Hongzhi Chen, Mengjie Jiang, Ping Jiang, Qian Wang, Xuemei Wang, Ruohong Chen, Haoneng Tang, Lingli Tang

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Foods (Basel, Switzerland) · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Heat-InactivatedFoods (Basel, Switzerland) · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Danning XuDepartment of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Siqi ZhuangDepartment of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hongzhi ChenNational Clinical Research Center for Metabolic Disease, Key Laboratory of Diabetes Immunology, Ministry of Education, Metabolic Syndrome Research Center, and Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Mengjie JiangDepartment of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Ping JiangDepartment of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Qian WangDepartment of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xuemei WangDepartment of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Ruohong ChenDepartment of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Haoneng Tang *Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. 505462@csu.edu.cn.
Lingli Tang *Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. linglitang@csu.edu.cn.
Second Xiangya Hospital of Central South University · CNCentral South University · CN

Funding

the Natural Scientific Foundation of Hunan Province 2021JJ40867
6 · The paper itself

Abstract

Interleukin-33 (IL-33), an emerging cytokine within the IL-1 family, assumes a pivotal function in the control of obesity. However, the specific mechanism of its regulation of obesity formation remains unclear. In this study, we found that the expression level of IL-33 increased in visceral adipose tissue in mice fed with a high-fat diet (HFD) compared with that in mice fed with a normal diet (ND). In vitro, we also found the expression level of IL-33 was upregulated during the adipogenesis of 3T3-L1 cells. Functional test results showed that knockdown of IL-33 in 3T3-L1 cells differentiation could promote the accumulation of lipid droplets, the content of triglyceride and the expression of adipogenic-related genes (i.e. PPAR-γ, C/EBPα, FABP4, LPL, Adipoq and CD36). In contrast, overexpression of IL-33 inhibits adipogenic differentiation. Meanwhile, the above tests were repeated after over-differentiation of 3T3-L1 cells induced by oleic acid, and the results showed that IL-33 played a more significant role in the regulation of adipogenesis. To explore the mechanism, transcriptome sequencing was performed and results showed that IL-33 regulated the PPAR signaling pathway in 3T3-L1 cells. Further, Western blot and confocal microscopy showed that the inhibition of IL-33 could promote PPAR-γ expression by inhibiting the Wnt/β-catenin signal in 3T3-L1 cells. This study demonstrated that IL-33 was an important regulator of preadipocyte differentiation and inhibited adipogenesis by regulating the Wnt/β-catenin/PPAR-γ signaling pathway, which provided a new insight for further research on IL-33 as a new intervention target for metabolic disorders.

Indexed as

AdipogenesisInterleukin-33Wnt Signaling PathwayAdipocytesAnimalsbeta CateninCell DifferentiationMiceObesityPPAR gammabeta CateninInterleukin-33PPAR gamma3T3-L1 cellsAdipogenesisInterleukin-33ObesityPPAR gammaWnt/β-catenin

Identifiers

PMID38632591
PMCPMC11022325
OpenAlexW4394883385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.